Effect of Elevated Pulmonary Vascular Resistance on Outcomes After Percutaneous Mitral Valvuloplasty
Ignacio Cruz‐González(Instituto de Investigación Biomédica de Salamanca), Igor F. Palacios(Massachusetts General Hospital), Hani Jneid(The University of Texas MD Anderson Cancer Center), María Sánchez Ledesma(Complejo Hospitalario de Salamanca), Ignacio Inglessis‐Azuaje(Harvard University), Pablo Rengifo‐Moreno(Harvard University), Roberto J. Cubeddu(Harvard University), Javier Martín‐Moreiras(Complejo Hospitalario de Salamanca), Andrew Maree(Harvard University), Marc J. Semigram(Harvard University), Pedro L. Sánchez(Instituto de Investigación Biomédica de Salamanca)
Cited by 7
Related Papers
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
|Journal of the American College of Cardiology|2014|3.6k
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary
|Circulation|2014|1.3k
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
|Circulation|2014|1.1k
Frailty in Older Adults Undergoing Aortic Valve Replacement
|Journal of the American College of Cardiology|2017|785